CureVac says its vaccine handed a primary evaluation but it surely has but to launch efficacy…
The German company CureVac announced on Friday that its vaccine against Covid-19 had passed its first interim analysis but was not yet ready to share data on how well it protects against infections. The shot could be cheaper and more…